ESC 365 - Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD

ESC Professional Premium Access

Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD

Session: Complexities in coronary artery disease

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor B. Kurt (Aachen, DE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Berkan Kurt

RWTH University Hospital Aachen, Aachen (Germany)

0 follower

5 more presentations in this session

Guideline-directed medical therapy implementation changes after acute coronary syndrome and their effect of prognosis: insights from Japanese real-world database using a storage system

Speaker: Doctor N. Akashi (Saitama, JP)

Galectin-3 and cancer mortality in patients with suspected or known coronary artery disease: the ANOX study

Speaker: Doctor H. Wada (Kyoto, JP)

Detection of chronic obstructive pulmonary disease and frequency of cardiopulmonary events in patients with a significant smoking history hospitalised for acute myocardial infarction

Speaker: Doctor W. Parker (Sheffield, GB)

Impaired high-density lipoprotein-associated cholesterol efflux capacity predicts coronary rapid plaque progression

Speaker: Doctor S. Feng (Shanghai, CN)

Alginate-chitosan hydrogel formulations for VEGFA expressed baculovirus delivery promoting angiogenesis for wound healing and revascularization

Speaker: Ms P. Islam (Montreal, CA)

Access the full session

Complexities in coronary artery disease

Speakers: Doctor B. Kurt, Doctor N. Akashi, Doctor H. Wada, Doctor W. Parker, Doctor S. Feng...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources